Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Relmada Therapeutics Inc (NASDAQ: RLMD) closed at $4.17 down -1.65% from its previous closing price of $4.24. In other words, the price has decreased by -$1.65 from its previous closing price. On the day, 0.88 million shares were traded. RLMD stock price reached its highest trading level at $4.35 during the session, while it also had its lowest trading level at $3.95.
Ratios:
For a deeper understanding of Relmada Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 05, 2024, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $23 to $1.
Jefferies Upgraded its Hold to Buy on September 17, 2024, whereas the target price for the stock was revised from $3.50 to $13.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 05 ’25 when Shenouda Maged bought 500,000 shares for $2.20 per share. The transaction valued at 1,100,000 led to the insider holds 788,335 shares of the business.
Ence Chuck bought 136,000 shares of RLMD for $299,200 on Nov 05 ’25. The CAO and COO now owns 403,931 shares after completing the transaction at $2.20 per share. On Nov 05 ’25, another insider, TRAVERSA SERGIO, who serves as the Chief Executive Officer of the company, bought 272,500 shares for $2.20 each. As a result, the insider paid 599,500 and bolstered with 1,272,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 305801216 and an Enterprise Value of 297048032.
Stock Price History:
The Beta on a monthly basis for RLMD is 0.79, which has changed by 8.021276 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, RLMD has reached a high of $5.12, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 40.64%, while the 200-Day Moving Average is calculated to be 240.49%.
Shares Statistics:
For the past three months, RLMD has traded an average of 994.21K shares per day and 911480 over the past ten days. A total of 73.33M shares are outstanding, with a floating share count of 50.90M. Insiders hold about 30.59% of the company’s shares, while institutions hold 14.57% stake in the company. Shares short for RLMD as of 1763078400 were 946511 with a Short Ratio of 0.95, compared to 1760486400 on 562426. Therefore, it implies a Short% of Shares Outstanding of 946511 and a Short% of Float of 1.2999999.
